COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 |
| | | VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY |
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
2seventy bio, Inc. | COMMON STOCK | 901384107 | 27,228 | 2,062,744 | SH | | SOLE | | 2,062,744 | 0 | 0 |
AbCellera Biologics Inc. | COM | 00288U106 | 111,294 | 10,450,180 | SH | | SOLE | | 10,450,180 | 0 | 0 |
ACADIA Pharmaceuticals Inc. | COM | 004225108 | 590,702 | 41,923,486 | SH | | SOLE | | 41,923,486 | 0 | 0 |
Achilles Therapeutics plc | SPONSORED ADS | 00449L102 | 6,530 | 2,591,366 | SH | | SOLE | | 2,591,366 | 0 | 0 |
Adaptimmune Therapeutics plc | SPONSORED ADR | 00653A107 | 16,712 | 9,830,877 | SH | | SOLE | | 9,830,877 | 0 | 0 |
Aeglea BioTherapeutics, Inc. | COM | 00773J103 | 1,722 | 3,410,106 | SH | | SOLE | | 3,410,106 | 0 | 0 |
Aerovate Therapeutics, Inc. | COM | 008064107 | 32,354 | 2,070,010 | SH | | SOLE | | 2,070,010 | 0 | 0 |
Affimed N.V. | COM | N01045108 | 18,273 | 6,596,830 | SH | | SOLE | | 6,596,830 | 0 | 0 |
Akero Therapeutics, Inc. | COM | 00973Y108 | 1,119 | 118,378 | SH | | SOLE | | 118,378 | 0 | 0 |
Alector, Inc. | COM | 014442107 | 2,431 | 239,228 | SH | | SOLE | | 239,228 | 0 | 0 |
Aligos Therapeutics, Inc. | COM | 01626L105 | 2,512 | 2,076,400 | SH | | SOLE | | 2,076,400 | 0 | 0 |
Alkermes plc | SHS | G01767105 | 44,685 | 1,500,000 | SH | | SOLE | | 1,500,000 | 0 | 0 |
Allakos Inc. | COM | 01671P100 | 2,201 | 703,050 | SH | | SOLE | | 703,050 | 0 | 0 |
Altimmune, Inc. | COM | 02155H200 | 24,282 | 2,075,403 | SH | | SOLE | | 2,075,403 | 0 | 0 |
Amarin Corporation plc | SPONSORED ADR | 023111206 | 31,543 | 21,169,805 | SH | | SOLE | | 21,169,805 | 0 | 0 |
AnaptysBio, Inc. | COM | 032724106 | 8,672 | 427,179 | SH | | SOLE | | 427,179 | 0 | 0 |
argenx SE | SPONSORED ADR | 04016X101 | 424,178 | 1,119,557 | SH | | SOLE | | 1,119,557 | 0 | 0 |
Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 451,103 | 4,852,655 | SH | | SOLE | | 4,852,655 | 0 | 0 |
Atara Biotherapeutics, Inc. | COM | 046513107 | 5,797 | 744,186 | SH | | SOLE | | 744,186 | 0 | 0 |
Athira Pharma, Inc. | COM | 04746L104 | 3,175 | 1,040,834 | SH | | SOLE | | 1,040,834 | 0 | 0 |
Atreca, Inc. | CL A COM | 04965G109 | 6,324 | 3,532,760 | SH | | SOLE | | 3,532,760 | 0 | 0 |
aTyr Pharma, Inc. | COM | 002120202 | 1,060 | 374,395 | SH | | SOLE | | 374,395 | 0 | 0 |
BeiGene, Ltd. | SPONSORED ADR | 07725L102 | 1,888,611 | 11,668,897 | SH | | SOLE | | 11,668,897 | 0 | 0 |
Bellicum Pharmaceuticals, Inc. | COM | 079481404 | 296 | 249,123 | SH | | SOLE | | 249,123 | 0 | 0 |
BioAtla, Inc. | COM | 09077B104 | 2,351 | 825,000 | SH | | SOLE | | 825,000 | 0 | 0 |
BioCryst Pharmaceuticals, Inc. | COM | 09058V103 | 134,480 | 12,710,818 | SH | | SOLE | | 12,710,818 | 0 | 0 |
BioMarin Pharmaceutical Inc. | COM | 09061G101 | 631,510 | 7,620,494 | SH | | SOLE | | 7,620,494 | 0 | 0 |
Biomea Fusion, Inc. | COM | 09077A106 | 25,213 | 2,104,559 | SH | | SOLE | | 2,104,559 | 0 | 0 |
bluebird bio, Inc. | COM | 09609G100 | 10,349 | 2,499,715 | SH | | SOLE | | 2,499,715 | 0 | 0 |
Burning Rock Biotech Limited | SPONSORED ADS | 12233L107 | 609 | 209,131 | SH | | SOLE | | 209,131 | 0 | 0 |
Cabaletta Bio, Inc. | COM | 12674W109 | 702 | 662,063 | SH | | SOLE | | 662,063 | 0 | 0 |
Centessa Pharmaceuticals plc | SPONSORED ADS | 152309100 | 5,490 | 1,127,273 | SH | | SOLE | | 1,127,273 | 0 | 0 |
Cerus Corporation | COM | 157085101 | 84,997 | 16,067,558 | SH | | SOLE | | 16,067,558 | 0 | 0 |
ChemoCentryx, Inc. | COM | 16383L106 | 44,422 | 1,792,657 | SH | | SOLE | | 1,792,657 | 0 | 0 |
Chinook Therapeutics, Inc. | COM | 16961L106 | 44,321 | 2,534,102 | SH | | SOLE | | 2,534,102 | 0 | 0 |
Crinetics Pharmaceuticals, Inc. | COM | 22663K107 | 15,433 | 827,480 | SH | | SOLE | | 827,480 | 0 | 0 |
CymaBay Therapeutics, Inc. | COM | 23257D103 | 6,403 | 2,170,464 | SH | | SOLE | | 2,170,464 | 0 | 0 |
Cyteir Therapeutics, Inc. | COM | 23284P103 | 7,904 | 2,643,640 | SH | | SOLE | | 2,643,640 | 0 | 0 |
DBV Technologies S.A. | SPONSORED ADR | 23306J101 | 37,266 | 14,614,264 | SH | | SOLE | | 14,614,264 | 0 | 0 |
Denali Therapeutics Inc. | COM | 24823R105 | 17,327 | 588,738 | SH | | SOLE | | 588,738 | 0 | 0 |
Design Therapeutics, Inc. | COM | 25056L103 | 20,113 | 1,436,636 | SH | | SOLE | | 1,436,636 | 0 | 0 |
DICE Therapeutics, Inc. | COM | 23345J104 | 9,129 | 588,235 | SH | | SOLE | | 588,235 | 0 | 0 |
Edgewise Therapeutics, Inc. | COM | 28036F105 | 3,980 | 500,000 | SH | | SOLE | | 500,000 | 0 | 0 |
Entrada Therapeutics, Inc. | COM | 29384C108 | 59,266 | 4,865,819 | SH | | SOLE | | 4,865,819 | 0 | 0 |
Epizyme, Inc. | COM | 29428V104 | 1,470 | 1,000,000 | SH | | SOLE | | 1,000,000 | 0 | 0 |
Evofem Biosciences, Inc. | COM | 30048L203 | 2,919 | 2,583,616 | SH | | SOLE | | 2,583,616 | 0 | 0 |
FibroGen, Inc. | COM | 31572Q808 | 8,614 | 815,718 | SH | | SOLE | | 815,718 | 0 | 0 |
Foghorn Therapeutics Inc. | COM | 344174107 | 612 | 45,027 | SH | | SOLE | | 45,027 | 0 | 0 |
Forma Therapeutics Holdings, Inc. | SHS | 34633R104 | 13,951 | 2,024,876 | SH | | SOLE | | 2,024,876 | 0 | 0 |
Fulgent Genetics, Inc. | COM | 359664109 | 10,985 | 201,444 | SH | | SOLE | | 201,444 | 0 | 0 |
Genetron Holdings Limited | ADS | 37186H100 | 774 | 455,306 | SH | | SOLE | | 455,306 | 0 | 0 |
Global Blood Therapeutics, Inc. | COM | 37890U108 | 119,253 | 3,732,502 | SH | | SOLE | | 3,732,502 | 0 | 0 |
Harmony Biosciences Holdings, Inc. | COM | 413197104 | 6,028 | 123,600 | SH | | SOLE | | 123,600 | 0 | 0 |
Heron Therapeutics, Inc. | COM | 427746102 | 22,687 | 8,131,678 | SH | | SOLE | | 8,131,678 | 0 | 0 |
HOOKIPA Pharma Inc. | COM | 43906K100 | 3,913 | 2,400,481 | SH | | SOLE | | 2,400,481 | 0 | 0 |
Horizon Therapeutics Public Ltd Co | SHS | G46188101 | 91,605 | 1,148,504 | SH | | SOLE | | 1,148,504 | 0 | 0 |
IGM Biosciences, Inc. | COM | 449585108 | 56,905 | 3,156,102 | SH | | SOLE | | 3,156,102 | 0 | 0 |
Immatics N.V. | SHS | N44445109 | 38,531 | 4,423,731 | SH | | SOLE | | 4,423,731 | 0 | 0 |
Immunocore Holdings plc | ADS | 45258D105 | 94,048 | 2,520,730 | SH | | SOLE | | 2,520,730 | 0 | 0 |
Incyte Corporation | COM | 45337C102 | 2,746,628 | 36,154,117 | SH | | SOLE | | 36,154,117 | 0 | 0 |
Inozyme Pharma, Inc. | COM | 45790W108 | 510 | 106,999 | SH | | SOLE | | 106,999 | 0 | 0 |
Insmed Incorporated | COM PAR $.01 | 457669307 | 42,516 | 2,156,001 | SH | | SOLE | | 2,156,001 | 0 | 0 |
Instil Bio, Inc. | COM | 45783C101 | 17,989 | 3,893,700 | SH | | SOLE | | 3,893,700 | 0 | 0 |
Invitae Corporation | COM | 46185L103 | 24,091 | 9,873,488 | SH | | SOLE | | 9,873,488 | 0 | 0 |
iTeos Therapeutics, Inc. | COM | 46565G104 | 3,097 | 150,346 | SH | | SOLE | | 150,346 | 0 | 0 |
Karuna Therapeutics, Inc. | COM | 48576A100 | 8,851 | 69,966 | SH | | SOLE | | 69,966 | 0 | 0 |
Kezar Life Sciences, Inc. | COM | 49372L100 | 512 | 61,946 | SH | | SOLE | | 61,946 | 0 | 0 |
Kiniksa Pharmaceuticals, Ltd. | COM CL A | G5269C101 | 27,128 | 2,799,577 | SH | | SOLE | | 2,799,577 | 0 | 0 |
Kodiak Sciences Inc. | COM | 50015M109 | 132,252 | 17,310,490 | SH | | SOLE | | 17,310,490 | 0 | 0 |
Krystal Biotech, Inc. | COM | 501147102 | 53,036 | 807,735 | SH | | SOLE | | 807,735 | 0 | 0 |
Kymera Therapeutics, Inc. | COM | 501575104 | 56,704 | 2,879,825 | SH | | SOLE | | 2,879,825 | 0 | 0 |
Leap Therapeutics, Inc. | COM | 52187K101 | 644 | 559,705 | SH | | SOLE | | 559,705 | 0 | 0 |
Legend Biotech Corporation | SPONSORED ADS | 52490G102 | 47,116 | 856,658 | SH | | SOLE | | 856,658 | 0 | 0 |
LogicBio Therapeutics, Inc. | COM | 54142F102 | 158 | 451,478 | SH | | SOLE | | 451,478 | 0 | 0 |
MacroGenics, Inc. | COM | 556099109 | 2,633 | 892,579 | SH | | SOLE | | 892,579 | 0 | 0 |
Madrigal Pharmaceuticals, Inc. | COM | 558868105 | 107,314 | 1,499,213 | SH | | SOLE | | 1,499,213 | 0 | 0 |
Merus N.V. | COM | N5749R100 | 22,536 | 995,397 | SH | | SOLE | | 995,397 | 0 | 0 |
Mirati Therapeutics, Inc. | COM | 60468T105 | 94,639 | 1,409,784 | SH | | SOLE | | 1,409,784 | 0 | 0 |
Natera, Inc. | COM | 632307104 | 3,544 | 100,000 | SH | | SOLE | | 100,000 | 0 | 0 |
Neoleukin Therapeutics, Inc. | COM | 64049K104 | 3,936 | 3,821,740 | SH | | SOLE | | 3,821,740 | 0 | 0 |
NexImmune, Inc. | COM | 65344D109 | 32 | 20,000 | SH | | SOLE | | 20,000 | 0 | 0 |
NGM Biopharmaceuticals, Inc. | COM | 62921N105 | 709 | 55,294 | SH | | SOLE | | 55,294 | 0 | 0 |
Nkarta, Inc. | COM | 65487U108 | 4,928 | 400,000 | SH | | SOLE | | 400,000 | 0 | 0 |
Nurix Therapeutics, Inc. | COM | 67080M103 | 49,187 | 3,882,125 | SH | | SOLE | | 3,882,125 | 0 | 0 |
Opthea Limited | SPONSORED ADS | 68386J208 | 16,986 | 2,696,191 | SH | | SOLE | | 2,696,191 | 0 | 0 |
Otonomy, Inc. | COM | 68906L105 | 17,498 | 8,412,634 | SH | | SOLE | | 8,412,634 | 0 | 0 |
Pacific Biosciences of California, Inc. | COM | 69404D108 | 24,067 | 5,444,963 | SH | | SOLE | | 5,444,963 | 0 | 0 |
Passage Bio, Inc. | COM | 702712100 | 276 | 117,161 | SH | | SOLE | | 117,161 | 0 | 0 |
Prelude Therapeutics Inc. | COM | 74065P101 | 52,846 | 10,123,824 | SH | | SOLE | | 10,123,824 | 0 | 0 |
Protara Therapeutics, Inc. | COM STK | 74365U107 | 585 | 199,671 | SH | | SOLE | | 199,671 | 0 | 0 |
Reata Pharmaceuticals, Inc. | CL A | 75615P103 | 6,807 | 223,976 | SH | | SOLE | | 223,976 | 0 | 0 |
Relmada Therapeutics, Inc. | COM | 75955J402 | 9,402 | 495,113 | SH | | SOLE | | 495,113 | 0 | 0 |
Replimune Group, Inc. | COM | 76029N106 | 62,772 | 3,591,081 | SH | | SOLE | | 3,591,081 | 0 | 0 |
Revolution Medicines, Inc. | COM | 76155X100 | 4,331 | 222,222 | SH | | SOLE | | 222,222 | 0 | 0 |
Rhythm Pharmaceuticals, Inc. | COM | 76243J105 | 17,119 | 4,125,062 | SH | | SOLE | | 4,125,062 | 0 | 0 |
Seagen Inc. | COM | 81181C104 | 8,300,656 | 46,912,266 | SH | | SOLE | | 46,912,266 | 0 | 0 |
Sera Prognostics, Inc. | CLASS A COM | 81749D107 | 331 | 201,562 | SH | | SOLE | | 201,562 | 0 | 0 |
Surrozen, Inc. | COM | 86889P109 | 7,500 | 2,500,000 | SH | | SOLE | | 2,500,000 | 0 | 0 |
Surrozen, Inc. | W EXP 8/11/2026 | 86889P117 | 159 | 833,333 | SH | | SOLE | | 833,333 | 0 | 0 |
Syndax Pharmaceuticals, Inc. | COM | 87164F105 | 2,130 | 110,729 | SH | | SOLE | | 110,729 | 0 | 0 |
Talis Biomedical Corporation | COM | 87424L108 | 6,191 | 7,624,835 | SH | | SOLE | | 7,624,835 | 0 | 0 |
Tango Therapeutics, Inc. | COM | 87583X109 | 3,398 | 750,000 | SH | | SOLE | | 750,000 | 0 | 0 |
TCR2 Therapeutics Inc. | COM | 87808K106 | 2,184 | 753,064 | SH | | SOLE | | 753,064 | 0 | 0 |
Travere Therapeutics, Inc. | COM | 89422G107 | 79,959 | 3,300,009 | SH | | SOLE | | 3,300,009 | 0 | 0 |
Tricida, Inc. | COM | 89610F101 | 14,550 | 1,503,090 | SH | | SOLE | | 1,503,090 | 0 | 0 |
TScan Therapeutics, Inc. | COM | 89854M101 | 8,758 | 2,784,792 | SH | | SOLE | | 2,784,792 | 0 | 0 |
Ultragenyx Pharmaceutical Inc. | COM | 90400D108 | 28,098 | 470,974 | SH | | SOLE | | 470,974 | 0 | 0 |
Vera Therapeutics, Inc. | CL A | 92337R101 | 4,537 | 333,333 | SH | | SOLE | | 333,333 | 0 | 0 |
Verastem, Inc. | COM | 92337C104 | 31,307 | 26,988,898 | SH | | SOLE | | 26,988,898 | 0 | 0 |
Verve Therapeutics, Inc. | COM | 92539P101 | 21,645 | 1,416,530 | SH | | SOLE | | 1,416,530 | 0 | 0 |
Vincerx Pharma, Inc. | COM | 92731L106 | 319 | 241,379 | SH | | SOLE | | 241,379 | 0 | 0 |
Vor Biopharma Inc. | COM | 929033108 | 5,660 | 1,138,768 | SH | | SOLE | | 1,138,768 | 0 | 0 |
Xenon Pharmaceuticals Inc. | COM | 98420N105 | 22,865 | 751,639 | SH | | SOLE | | 751,639 | 0 | 0 |
Zymeworks Inc. | COM | 98985W102 | 9,055 | 1,708,472 | SH | | SOLE | | 1,708,472 | 0 | 0 |
Insmed Incorporated | Note 0.75% 6/1/2028 | 457669AB5 | 33,278 | 40,000,000 | PRN | | SOLE | | 40,000,000 | 0 | 0 |
Invitae Corporation | Note 2.0% 9/1/2024 | 46185LAB9 | 8,087 | 10,300,000 | PRN | | SOLE | | 10,300,000 | 0 | 0 |
Sarepta Therapeutics, Inc. | DBCV 1.5% 11/15/2024 | 803607AB6 | 36,577 | 29,174,000 | PRN | | SOLE | | 29,174,000 | 0 | 0 |